{"id":"https://openalex.org/W4362629602","doi":"https://doi.org/10.1158/2643-3230.22543689.v1","title":"Supplementary Data from Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis","display_name":"Supplementary Data from Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362629602","doi":"https://doi.org/10.1158/2643-3230.22543689.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2643-3230.22543689.v1","doi":"https://doi.org/10.1158/2643-3230.22543689.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.22543689.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2643-3230.22543689.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062376578","display_name":"Victoria E. H. Wang","orcid":"https://orcid.org/0000-0001-9052-3531","observed_orcids":["https://orcid.org/0000-0001-9052-3531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victoria E. Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006168813","display_name":"Bradley Wayne Blaser","orcid":"https://orcid.org/0000-0002-3168-5423","observed_orcids":["https://orcid.org/0000-0002-3168-5423"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley W. Blaser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048012003","display_name":"Ravi K. Patel","orcid":"https://orcid.org/0000-0001-5203-899X","observed_orcids":["https://orcid.org/0000-0001-5203-899X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravi K. Patel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5203-899X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024815439","display_name":"Gregory K. Behbehani","orcid":"https://orcid.org/0000-0002-9493-3607","observed_orcids":["https://orcid.org/0000-0002-9493-3607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory K. Behbehani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025368177","display_name":"Arjun Arkal Rao","orcid":"https://orcid.org/0000-0003-4480-3190","observed_orcids":["https://orcid.org/0000-0003-4480-3190"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arjun A. Rao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062912806","display_name":"Blythe P Durbin-Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Blythe Durbin-Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Tommy Jiang","orcid":"https://orcid.org/0000-0002-1199-0615","observed_orcids":["https://orcid.org/0000-0002-1199-0615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tommy Jiang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1199-0615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071733656","display_name":"Aaron C. Logan","orcid":"https://orcid.org/0000-0002-1179-5879","observed_orcids":["https://orcid.org/0000-0002-1179-5879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron C. Logan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1179-5879","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057455952","display_name":"Matthew Lee Settles","orcid":"https://orcid.org/0000-0002-3424-1086","observed_orcids":["https://orcid.org/0000-0002-3424-1086"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Settles","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085672843","display_name":"Gabriel N. Mannis","orcid":"https://orcid.org/0009-0000-8202-0870","observed_orcids":["https://orcid.org/0009-0000-8202-0870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel N. Mannis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068817380","display_name":"Rebecca Leah Olin","orcid":"https://orcid.org/0000-0002-5060-0384","observed_orcids":["https://orcid.org/0000-0002-5060-0384"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Olin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061334352","display_name":"Lloyd Earl Damon","orcid":"https://orcid.org/0000-0002-7934-5321","observed_orcids":["https://orcid.org/0000-0002-7934-5321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lloyd E. Damon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7934-5321","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059086219","display_name":"Thomas G. Martin","orcid":"https://orcid.org/0000-0002-9133-9813","observed_orcids":["https://orcid.org/0000-0002-9133-9813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas G. Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044936210","display_name":"Peter H. Sayre","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter H. Sayre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966885","display_name":"Karin M. L. Gaensler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karin M. Gaensler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Emma McMahon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emma McMahon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087903876","display_name":"Michael Flanders","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Flanders","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039728792","display_name":"VIVIAN K. WEINBERG","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Weinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005819504","display_name":"Chun Ye","orcid":"https://orcid.org/0000-0001-6560-3783","observed_orcids":["https://orcid.org/0000-0001-6560-3783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun J. Ye","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059652753","display_name":"David Paul Carbone","orcid":"https://orcid.org/0000-0003-3002-1921","observed_orcids":["https://orcid.org/0000-0003-3002-1921"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David P. Carbone","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3002-1921","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083373965","display_name":"Pamela N. M\u00fcnster","orcid":"https://orcid.org/0000-0002-2074-0984","observed_orcids":["https://orcid.org/0000-0002-2074-0984","https://orcid.org/0009-0009-4141-2312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pamela N. Munster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087928119","display_name":"Gabriela K. Fragiadakis","orcid":"https://orcid.org/0000-0001-9703-2591","observed_orcids":["https://orcid.org/0000-0001-9703-2591"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriela K. Fragiadakis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082685256","display_name":"Frank P. McCormick","orcid":"https://orcid.org/0000-0002-6619-7120","observed_orcids":["https://orcid.org/0000-0002-6619-7120"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank McCormick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6619-7120","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068715900","display_name":"Charalambos Babis Andreadis","orcid":"https://orcid.org/0000-0003-4681-6227","observed_orcids":["https://orcid.org/0000-0003-4681-6227"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charalambos Andreadis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/refractory-acute-myeloid-leukemia","display_name":"refractory acute myeloid leukemia","score":0.9440000057220459},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.753000020980835},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.777999997138977},{"id":"https://openalex.org/keywords/high-dimensional-analysis","display_name":"high-dimensional analysis","score":0.7829999923706055},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6893290877342224},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5577921271324158},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44876715540885925},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4340569078922272},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4209108352661133},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0992162823677063},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2643-3230.22543689.v1","doi":"https://doi.org/10.1158/2643-3230.22543689.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.22543689.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22543689","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Data_from_Inhibition_of_MET_Signaling_with_Ficlatuzumab_in_Combination_with_Chemotherapy_in_Refractory_AML_Clinical_Outcomes_and_High-Dimensional_Analysis/22543689","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/2643-3230.22543689.v1","doi":"https://doi.org/10.1158/2643-3230.22543689.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2643-3230.22543689.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3185291790","https://openalex.org/W4362546921","https://openalex.org/W2892053009","https://openalex.org/W3193324207","https://openalex.org/W4361950443","https://openalex.org/W4242439176","https://openalex.org/W7108502605","https://openalex.org/W4311928498","https://openalex.org/W4361956326","https://openalex.org/W2955911927"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Inhibition":[3],"of":[4],"MET":[5],"Signaling":[6],"with":[7,11],"Ficlatuzumab":[8],"in":[9,13],"Combination":[10],"Chemotherapy":[12],"Refractory":[14],"AML:":[15],"Clinical":[16],"Outcomes":[17],"and":[18],"High-Dimensional":[19],"Analysis":[20]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-07T00:00:00"}